Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

652
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
652
Cognitive Therapy01:25

Cognitive Therapy

688
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
688
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.1K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.1K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

473
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
473
Behavior Therapy01:22

Behavior Therapy

360
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biological and Social Risk Factors for Predicting Type 2 Diabetes in Youth with Prediabetes: Review of Existing Prediction Models.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author

A Pilot Randomized Controlled Trial of the Autism Mentorship Program.

Journal of autism and developmental disorders·2026
Same author

ATP bioenergetics and fatigue in young adults with and without major depression.

Translational psychiatry·2026
Same author

Dynamic Functional Connectivity, Major Depression, and Suicidal Ideation in Children.

Human brain mapping·2026
Same author

Examining Causal Pathways to Suicidal Ideation and Nonsuicidal Self-Injury in the Adolescent Brain Cognitive Development Study.

Suicide & life-threatening behavior·2025
Same author

Mortality cues in a high-resource context: Minority stress, suicide exposure, and pubertal development.

The Behavioral and brain sciences·2025

Related Experiment Video

Updated: Dec 8, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.4K

Developing a data-driven algorithm for guiding selection between cognitive behavioral therapy, fluoxetine, and

Meredith Gunlicks-Stoessel1, Bonnie Klimes-Dougan2, Adrienne VanZomeren3

  • 1Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA. mgunlick@umn.edu.

Translational Psychiatry
|September 22, 2020
PubMed
Summary

This study developed a machine-learning algorithm to personalize adolescent depression treatment. The model identifies which patients benefit most from cognitive-behavioral therapy, fluoxetine, or combination therapy for better outcomes.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.9K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.1K

Related Experiment Videos

Last Updated: Dec 8, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.4K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.9K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.1K

Area of Science:

  • Psychiatry
  • Computational Psychiatry
  • Clinical Psychology

Background:

  • Effective treatment for adolescent depression necessitates personalized interventions tailored to individual patient needs.
  • The Treatment for Adolescents with Depression (TAD) study provided a rich dataset for exploring treatment response predictors.

Purpose of the Study:

  • To develop a machine-learning algorithm for matching adolescents with major depressive disorder to optimal treatments: cognitive-behavioral therapy (CBT), fluoxetine (FLX), or combination treatment (COMB).
  • To predict treatment response using demographic, clinical, and psychosocial data collected prior to treatment.

Main Methods:

  • Leveraged data from the TAD clinical trial.
  • Employed machine-learning techniques to build a predictive model for treatment response, measured by the week 12 Children's Depression Rating Scale-Revised (CDRS-R).

Main Results:

  • The model successfully identified patient subgroups with preferential responses to specific treatments.
  • A subgroup (25%) showed a significant CDRS-R benefit with FLX over CBT (16.9 points).
  • Another subgroup (50%) experienced greater benefit from COMB compared to CBT (up to 19.0 points).
  • Physical illness and disability predicted general treatment response, while baseline CDRS-R, psychosomatic symptoms, school absenteeism, self-perception, treatment expectations, and attention problems predicted specific treatment response.

Conclusions:

  • The developed algorithm serves as a foundation for personalized treatment selection in adolescent depression.
  • This approach can optimize treatment matching, potentially improving outcomes for adolescents with major depressive disorder.